申请人:Merck Patent Gesellschaft mit beschrankter Haftung
公开号:US05227386A1
公开(公告)日:1993-07-13
3-(3-Indolyl)quinuclidines for the formula I Ind--R I in which Ind is a 3-indolyl group which is unsubstituted or monosubstituted to tetrasubstituted by C.sub.1-4 -alkyl, trifluoromethyl, C.sub.1-4 -alkoxy, C.sub.1-4 -alkylthio, fluorine, chlorine, hydroxyl, hydroxymethyl, C.sub.6-10 -aryloxy, C.sub.7-11 -aralkyloxy, C.sub.1-5 -acyloxy, C.sub.6-10 -aroyloxy, C.sub.1-4 -alkylsulfonyloxy, C.sub.6-10 -arylsulfonyloxy, carboxyl, C.sub.1-4 -alkoxycarbonyl and/or methylenedioxy and R is 3-quinuclidinyl or 2,3-dehydro-3-quinuclidinyl, and their physiologically acceptable salts can be used as psychopharmaceuticals.
公式I中的3-(3-吲哚基)喹诺啡啶,其中Ind是3-吲哚基基团,未取代或通过C.sub.1-4-烷基,三氟甲基,C.sub.1-4-烷氧基,C.sub.1-4-烷基硫基,氟,氯,羟基,羟甲基,C.sub.6-10-芳氧基,C.sub.7-11-芳基烷氧基,C.sub.1-5-酰氧基,C.sub.6-10-芳酰氧基,C.sub.1-4-烷基磺酰氧基,C.sub.6-10-芳磺酰氧基,羧基,C.sub.1-4-烷氧羰基和/或亚甲二氧基单取代到四取代,而R是3-喹诺啡啶基或2,3-脱氢-3-喹诺啡啶基,它们的生理上可接受的盐可用作精神药物。